3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
15
Precursor Cell Lymphoblastic Leukemia-Lymphoma
12
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Leukemia, Myeloid, Accelerated Phase
3
Down Syndrome
3
Blast Crisis
3
Osteosarcoma
2
Myeloproliferative Disorders
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Anemia, Refractory, with Excess of Blasts
2
Waldenstrom Macroglobulinemia
1
Urothelial Carcinoma of the Bladder
1
Thrombocythemia, Essential
1
Sezary Syndrome
1
Sarcoma, Ewing
1
Rhabdoid Tumor
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Recurrence
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Neoplasms
1
Interventions
Platinum
3
Pemetrexed
3
Cisplatin
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
Radiotherapy
2
Radiation
2
cediranib
1
atezolizumab
1
Radiotherapy, Intensity-Modulated
1
Pharmacogenomic Testing
1
Combined Modality Therapy
1
Cerebral Decortication
1
Carboplatin
1
Brentuximab Vedotin
1
Blood Component Removal
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma, Malignant
×
Methotrexate
×
30 days
×
Clear all
No trials found.